+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on Pathogen Biology, Vaccines and Immunology · Registering as Listener

ICPBVI
📅 12 – 13 Mar 2027 📍 Liverpool, UK 👥 Standard / Physical Participation
Listener Registration From
$185
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on Pathogen Biology, Vaccines and Immunology
ModeStandard / Physical
ParticipationListener
Registration fee$185.00
Bank charges (5.8%)$10.73
Total payable $195.73

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 SDG 4 SDG 9 SDG 10

This track focuses on the intricate molecular interactions between pathogens and host cells. Understanding these mechanisms is crucial for developing targeted therapeutic strategies.

This session will explore the latest advancements in vaccine technology, including novel adjuvants and delivery systems. Emphasis will be placed on the rapid development of vaccines in response to emerging infectious diseases.

This track examines the immune responses elicited by various infectious agents, highlighting both innate and adaptive immunity. Insights gained will aid in the design of effective vaccines and immunotherapies.

This session will delve into the epidemiological trends and patterns of infectious diseases globally. Discussions will include risk factors, transmission dynamics, and the impact of public health interventions.

This track will present cutting-edge clinical research findings related to the diagnosis, treatment, and management of infectious diseases. Emphasis will be placed on translational research and its implications for patient care.

This session will focus on effective strategies for managing infectious disease outbreaks, including surveillance, containment, and communication. Case studies will provide insights into successful outbreak responses.

This track will address critical issues surrounding vaccine safety and efficacy, including adverse events and long-term outcomes. Discussions will aim to enhance public trust in vaccination programs.

This session will explore the evolutionary dynamics of pathogens and the emergence of antimicrobial resistance. Understanding these trends is essential for developing effective control measures.

This track will investigate the role of immunotherapy in the treatment of infectious diseases, including monoclonal antibodies and immune checkpoint inhibitors. The potential for harnessing the immune system to combat infections will be emphasized.

This session will provide a global perspective on the burden of infectious diseases and the challenges faced in different regions. Discussions will include health disparities and the role of international collaboration in disease control.

This track will highlight emerging trends and future directions in immunology research related to infectious diseases. Topics will include novel therapeutic approaches and the integration of technology in immunological studies.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED